Holen Sie sich die Stockscreener-App
2.13
0.95%
0.02
Handel nachbörslich:
2.14
0.01
+0.47%
Schlusskurs vom Vortag:
$2.11
Offen:
$2.12
24-Stunden-Volumen:
650.67K
Relative Volume:
0.74
Marktkapitalisierung:
$190.53M
Einnahmen:
$70.14M
Nettoeinkommen (Verlust:
$-76.24M
KGV:
-1.9189
EPS:
-1.11
Netto-Cashflow:
$-57.06M
1W Leistung:
-7.39%
1M Leistung:
-16.47%
6M Leistung:
-35.26%
1J Leistung:
-24.73%
1-Tages-Spanne:
$2.10
$2.235
1-Wochen-Bereich:
$2.05
$2.35
52-Wochen-Spanne:
$1.90
$6.08
Codexis Inc Stock (CDXS) Company Profile
Firmenname
Codexis Inc
Sektor
Branche
Telefon
650-421-8100
Adresse
200 PENOBSCOT DRIVE, REDWOOD CITY, CA
Vergleichen Sie CDXS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CDXS
Codexis Inc
|
2.13 | 190.53M | 70.14M | -76.24M | -57.06M | -1.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.52 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.49 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
595.70 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
232.75 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
229.22 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Codexis Inc Stock (CDXS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-19 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-05-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-02-29 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2023-11-07 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2023-08-07 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2023-05-09 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2022-03-31 | Fortgesetzt | Piper Sandler | Overweight |
| 2022-03-02 | Fortgesetzt | Cowen | Outperform |
| 2021-04-12 | Eingeleitet | Piper Sandler | Overweight |
| 2021-03-01 | Eingeleitet | Stifel | Buy |
| 2021-02-26 | Bestätigt | H.C. Wainwright | Buy |
| 2020-03-10 | Eingeleitet | The Benchmark Company | Buy |
| 2019-01-17 | Hochstufung | First Analysis Sec | Neutral → Outperform |
| 2018-05-16 | Eingeleitet | Stephens | Overweight |
| 2017-10-13 | Bestätigt | H.C. Wainwright | Buy |
| 2017-05-31 | Eingeleitet | Jefferies | Buy |
| 2017-01-26 | Herabstufung | First Analysis Sec | Overweight → Equal-Weight |
| 2017-01-04 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2016-01-06 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Codexis Inc Aktie (CDXS) Neueste Nachrichten
Quarterly Snapshot: Quick and Current Ratios for Codexis Inc (CDXS) - DWinneX
Global Biocatalysis Market Growth Trends & Insights2024-2031 - openPR.com
LPL Financial LLC Buys 35,335 Shares of Codexis, Inc. (NASDAQ:CDXS) - Defense World
Metabolic Engineering Market Is Booming Worldwide 2025-2032 | Codexis, Inc.,Amyris, Inc.,Ginkgo Bioworks - openPR.com
Opaleye Management Makes a Bold Move with Major Codexis Stock Purchase - TipRanks
Codexis shares acquired by Opaleye Management total $298,772 - Investing.com Canada
Codexis shares acquired by Opaleye Management total $298,772 By Investing.com - Investing.com South Africa
Franklin Resources Inc. Increases Position in Codexis, Inc. (NASDAQ:CDXS) - Defense World
Vanguard Group Inc. Purchases 311,082 Shares of Codexis, Inc. (NASDAQ:CDXS) - Defense World
Major Investment Alert: Opaleye Management Inc. Boosts Stake in Codexis! - TipRanks
Codexis Announces Byron Dorgan to Retire from Board of Directors - GuruFocus
Codexis Announces Board Member Retirement in April 2025 - MSN
Veteran Chairman Byron Dorgan Exits Codexis Board: Key Details of Leadership Transition - Stock Titan
Codexis shares bought by Opaleye Management for $198,380 - Investing.com India
Is Now The Time To Buy Codexis Inc (NASDAQ: CDXS) Stock? - stocksregister.com
Codexis, Inc. (NASDAQ:CDXS) Shares Acquired by Commonwealth Equity Services LLC - Defense World
Codexis sees significant stock purchase by Opaleye Management, Inc. for $271,788 - Investing.com UK
Codexis stock hits 52-week low at $2.43 amid market challenges - Investing.com India
Codexis stock hits 52-week low at $2.43 amid market challenges By Investing.com - Investing.com South Africa
Protein Engineering Market Is Booming So Rapidly | Major Giants Merck KGaA, Agilent Technologies, Codexis - newstrail.com
5 "Best" Publicly Traded Synthetic Biology Companies - Securities.io
Codexis Appoints Cynthia Collins to Board of Directors - GlobeNewswire
RNA Pioneer and Former Editas CEO Joins Codexis Board: Strategic Move for RNA Therapeutics Push - Stock Titan
Codexis appoints new independent board member By Investing.com - Investing.com Canada
Charles Schwab Investment Management Inc. Purchases 26,052 Shares of Codexis, Inc. (NASDAQ:CDXS) - Defense World
Codexis appoints new independent board member - Investing.com India
Codexis, Inc. (NASDAQ:CDXS) Stocks Pounded By 27% But Not Lagging Industry On Growth Or Pricing - simplywall.st
Codexis, Inc. (NASDAQ:CDXS) Holdings Increased by Bank of New York Mellon Corp - Defense World
Codexis sees $236,283 in stock purchases by Opaleye management - Investing.com Australia
Opaleye Management Inc. Expands Stake in Codexis Inc. - GuruFocus
Codexis Announces First Revenue-Generating Contract for ECO Synthesis™ Manufacturing Services - GlobeNewswire
New Contract Propels Codexis (CDXS) Stock Upward, Signaling Market Optimism - Stocks Telegraph
Codexis Signs First Contract for ECO Synthesis Manufacturing Services -March 24, 2025 at 08:17 am EDT - MarketScreener
Codexis Inc (NASDAQ: CDXS): Should Value Hunters Buy It? - Stocks Register
Codexis Achieves Major Revenue Milestone: First ECO Synthesis Contract Signals Market Breakthrough - StockTitan
Opaleye Management Inc. Increases Stake in Codexis Inc. - GuruFocus
Codexis stock hits 52-week low at $2.47 amid market challenges By Investing.com - Investing.com South Africa
Codexis stock hits 52-week low at $2.47 amid market challenges - Investing.com India
Opaleye Management Inc. Boosts Investment in Codexis with Major Stock Purchase - TipRanks
Finanzdaten der Codexis Inc-Aktie (CDXS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.15%
4.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):